FDA — authorised 28 August 2015
- Marketing authorisation holder: REPATHA
- Status: approved
FDA authorised Repatha on 28 August 2015
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 28 August 2015.
REPATHA holds the US marketing authorisation.